ISSEDAK
DEAD

Serial Number

86228044

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 21, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ISSEDAK Trademark

Serial Number: 86228044

ISSEDAK is a trademark filed by NOVARTIS AG on March 21, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 21, 2014

Registration Date

Not Registered

Published for Opposition

July 8, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Sep 4, 2014 MAB5
ABANDONMENT - AFTER PUBLICATION
Sep 4, 2014 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Sep 2, 2014 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 23, 2014 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2014 NPUB
ASSIGNED TO EXAMINER
Jul 8, 2014 DOCK
PUBLISHED FOR OPPOSITION
Jul 8, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2014 CNSA
ASSIGNED TO EXAMINER
May 31, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2014 NWOS
NEW APPLICATION ENTERED
Mar 25, 2014 NWAP